Predictmedix AI Inc C.PMED

Alternate Symbol(s): PMEDF

Predictmedix AI Inc. is a Canada-based provider of rapid health screening and remote patient care solutions globally. The Company’s Safe Entry Stations, powered by artificial intelligence AI, use multispectral cameras to analyze physiological data patterns and predict a variety of health issues, including infectious diseases, such as COVID-19, impairment by drugs or alcohol, fatigue, or various mental illnesses. Its remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. Its solutions include Infectious Disease Screening, Impairment Screening, and Mobilewellbeing. The Infectious Disease Screening screen for COVID-19, its variants, and other infectious diseases. It offers cannabis and alcohol impairment screening. Mobilewellbeing is a software platform with patient monitoring devices. The Company’s autonomous, non-invasive, no-contact solutions detect symptoms before they spread through workplace.

CSE:PMED - Post by User

Predictmedix AI Inc > What Happened to Sales Contract?

<< Previous

Bullboard Posts

Next >>

Post by badog222on Feb 22, 2021 10:58am

159 Views

Post# 32626019

What Happened to Sales Contract?

Does anyone know what ever happened to the sales contract listed below? I have never seen any revenues reported by PMED period....let alone from what PMED called a significant sales contract with the following outfit.

July 7, 2020

Predictmedix announces its first significant UK sales contract

TORONTO, ON / ACCESSWIRE / July 7, 2020 / Predictmedix Inc. (PMED.CN)(PMEDF) ("Predictmedix" or the "Company") is pleased to announce the execution of a sales contract for its COVID-19 screening technology with Taurus Medical Solutions ("Taurus"), a medical distributor based out of the United Kingdom which is also a supplier to United Kingdom National Health Service "NHS".

July 7, 2020

Predictmedix announces its first significant UK sales contract

TORONTO, ON / ACCESSWIRE / July 7, 2020 / Predictmedix Inc. (PMED.CN)(PMEDF) ("Predictmedix" or the "Company") is pleased to announce the execution of a sales contract for its COVID-19 screening technology with Taurus Medical Solutions ("Taurus"), a medical distributor based out of the United Kingdom which is also a supplier to United Kingdom National Health Service "NHS". Furthermore, Predictmedix is also pleased to announce that it has filed two patent applications with the United States Patent and Trademark Office for its telehealth/telemedicine and remote patient monitoring platform.